Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61

FASEB Journal

Volumn 22, Issue 11, 2008, Pages 4011-4021

  Walsh, Colin T ^a   Radeff Huang, Julie ^a   Matteo, Rosalia ^a   Hsiao, Albert ^b   Subramaniam, Shankar ^b   Stupack, Dwayne ^c   Brown, Joan Heller ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G protein; Glioblastoma; Matricellular protein; PAR1; S1P receptor

Indexed keywords

ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; CARBACHOL; CYSTEINE RICH PROTEIN 61; INTEGRIN; MONOCLONAL ANTIBODY; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; THROMBIN RECEPTOR;

ARTICLE; ASTROCYTOMA CELL; CELL PROLIFERATION; CELL SURFACE; DNA SYNTHESIS; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTOMICS;

CARBACHOL; CARDIOTONIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; IMMEDIATE-EARLY PROTEINS; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTOR, PAR-1; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 55549110078     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-113266     Document Type: Article

References (77)

1. Dorsam, R. T., and Gutkind, J. S. (2007) G-protein-coupled receptors and cancer. Nat. Rev. Cancer 7, 79-94
2. Arora, P., Ricks, T. K., and Trejo, J. (2007) Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J. Cell Sci. 120, 921-928
3. Coughlin, S. R. (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814
4. McLaughlin, J. N., Shen, L., Holinstat, M., Brooks, J. D., Dibenedetto, E., and Hamm, H. E. (2005) Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J. Biol. Chem. 280, 25048-25059
5. 12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells. Mol. Biol. Cell 7, 1679-1690
6. Trejo, J., Chambard, J.-C., Karin, M., and Brown, J. H. (1992) Biphasic increase in c-jun mRNA is required for induction of AP-1 mediated gene transcription: differential effects of muscarinic and thrombin receptor activation. Mol. Cell. Biol. 12, 4742-4750
7. Aragay, A. M., Collins, L. R., Post, G. R., Watson, A. J., Feramisco, J. R., Brown, J. H., and Simon, M. I. (1995) G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J. Biol. Chem. 270, 20073-20077
8. Majumdar, M., Seasholtz, T. M., Goldstein, D., de Lanerolle, P., and Brown, J. H. (1998) Requirement for Rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis. J. Biol. Chem. 273, 10099-10106
9. Majumdar, M., Seasholtz, T. M., Buckmaster, C., Toksoz, D., and Brown, J. H. (1999) A Rho exchange factor mediates thrombin and Ga12-induced cytoskeletal responses. J. Biol. Chem. 274, 26815-26821
10. Ridley, A. J. (2001) Rho GTPases and cell migration. J. Cell. Sci. 114, 2713-2722
11. Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science 279, 509-514
12. Kaibuchi, K., Kuroda, S., and Amano, M. (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68, 459-486
13. Whitehead, I. P., Zohn, I. E., and Der, C. J. (2001) Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 20, 1547-1555
14. 12 to the serum response element and to cellular transformation. Proc. Natl. Acad. Sci. U. S. A. 91, 10098-10103
15. Waf1/Cip1. Nature 394, 295-299
16. Schwartz, M. A., Toksoz, D., and Khosravi-Far, R. (1996) Transformation by Rho exchange factor oncogenes is mediated by activation of an integrin-dependent pathway. EMBO J. 15, 6525-6530
17. Jiang, H., Wu, D., and Simon, M. I. (1993) The transforming activity of activated Ga12. FEBS Lett. 330, 319-322
18. Chan, A. M. L., Fleming, T. P., McGovern, E. S., Chedid, M., Miki, T., and Aaronson, S. A. (1993) Expression cDNA cloning of a transforming gene encoding the wild-type Ga12 gene product. Mol. Cell. Biol. 13, 762-768
19. Citro, S., Malik, S., Oestreich, E. A., Radeff-Huang, J., Kelley, G. G., Smrcka, A. V., and Brown, J. H. (2007) Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation. Proc. Natl. Acad. Sci. U. S. A. 104, 15543-15548
20. Marinissen, M. J., Chiariello, M., Tanos, T., Bernard, O., Narumiya, S., and Gutkind, J. S. (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol. Cell 14, 29-41
21. Lau, L. F., and Lam, S. C. T. (2005) Integrated-mediated CCN functions. In CCN Proteins: A New Family of Cell Growth and Differentiation Regulators (Perbal, B., and Takigawa, M., eds) pp. 61-79, Imperial College Press, London, UK
22. Yang, G. P., and Lau, L. F. (1991) Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ. 2, 351-357
23. Brigstock, D. R. (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5, 153-165
24. Lau, L. F., and Lam, S. C. (1999) The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 248, 44-57
25. Bleau, A. M., Planque, N., and Perbal, B. (2005) CCN proteins and cancer: two to tango. Front. Biosci. 10, 998-1009
26. Kireeva, M. L., Mo, F. E., Yang, G. P., and Lau, L. F. (1996) Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16, 1326-1334
27. Xie, D., Yin, D., Tong, X., O'Kelly, J., Mori, A., Miller, C., Black, K., Gui, D., Said, J. W., and Koeffler, H. P. (2004) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res. 64, 1987-1996
28. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., and Kuliopulos, A. (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313
29. Nguyen, N., Kuliopulos, A., Graham, R. A., and Covic, L. (2006) Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res. 66, 2658-2665
30. Han, J. S., Macarak, E., Rosenbloom, J., Chung, K. C., and Chaqour, B. (2003) Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. Eur. J. Biochem. 270, 3408-3421
31. Sakamoto, S., Yokoyama, M., Zhang, X., Prakash, K., Nagao, K., Hatanaka, T., Getzenberg, R. H., and Kakehi, Y. (2004) Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. Endocrinology 145, 2929-2940
32. Young, N., and Van, B., Jr. (2007) Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Exp. Cell Res. 313, 1615-1627
33. Liang, Y., Li, C., Guzman, V. M., Evinger, A. J., III, Protzman, C. E., Krauss, A. H., and Woodward, D. F. (2003) Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression. J. Biol. Chem. 278, 27267-27277
34. Wiedmaier, N., Muller, S., Koberle, M., Manncke, B., Krejci, J., Autenrieth, I. B., and Bohn, E. (2008) Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner. Int. J. Med. Microbiol. 298, 231-243
35. Pendurthi, U. R., Allen, K. E., Ezban, M., and Rao, L. V. (2000) Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction. J. Biol. Chem. 275, 14632-14641
36. Pendurthi, U. R., Ngyuen, M., ndrade-Gordon, P., Petersen, L. C., and Rao, L. V. (2002) Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler. Thromb. Vasc. Biol. 22, 1421-1426
37. Tamura, I., Rosenbloom, J., Macarak, E., and Chaqour, B. (2001) Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am. J. Physiol. Cell Physiol. 281, C1524-C1532
38. Leask, A., and Abraham, D. J. (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119, 4803-4810
39. Chen, N., Chen, C. C., and Lau, L. F. (2000) Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. J. Biol. Chem. 275, 24953-24961
40. Grzeszkiewicz, T. M., Kirschling, D. J., Chen, N., and Lau, L. F. (2001) CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J. Biol. Chem. 276, 21943-21950
41. Kireeva, M. L., Lam, S. C., and Lau, L. F. (1998) Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J. Biol. Chem. 273, 3090-3096
42. Ren, X.-D., Kiosses, W. B., and Schwartz, M. A. (1999) Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18, 578-585
43. Hsiao, A., Ideker, T., Olefsky, J. M., and Subramaniam, S. (2005) VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data. Nucleic Acids Res. 33, W627-W632
44. Hsiao, A., Worrall, D. S., Olefsky, J. M., and Subramaniam, S. (2004) Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes. Bioinformatics 20, 3108-3127
45. Radeff-Huang, J., Seasholtz, T. M., Chang, J. W., Smith, J. M., Walsh, C. T., and Brown, J. H. (2007) Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J. Biol. Chem. 282, 863-870
46. An, D. S., Morizono, K., Li, Q. X., Mao, S. H., Lu, S., and Chen, I. S. (1999) An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J. Virol. 73, 7671-7677
47. Stewart, S. A., Dykxhoorn, D. M., Palliser, D., Mizuno, H., Yu, E. Y., An, D. S., Sabatini, D. M., Chen, I. S., Hahn, W. C., Sharp, P. A., Weinberg, R. A., and Novina, C. D. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501
48. Seuwen, K., Kahan, C., Hartmann, T., and Pouyssegur, J. (1990) Strong and persistent activation of inositol lipid breakdown induces early mitogenic events but not Go to S phase progression in hamster fibroblasts. J. Biol. Chem. 265, 22292-22299
49. Aktories, K., Braun, U., Rosener, S., Just, I., and Hall, A. (1989) The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158, 209-213
50. Latinkic, B. V., O'Brien, T. P., and Lau, L. F. (1991) Promoter function and structure of the growth factor-inducible immediate early gene cyr61. Nucleic Acids Res. 19, 3261-3267
51. O'Brien, T. P., Yang, G. P., Sanders, L., and Lau, L. F. (1990) Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10, 3569-3577
52. Qui, R. G., Chen, J., Kirn, D., McCormick, F., and Symons, M. (1995) An essential role for Rac in Ras transformation. Nature 374, 457-459
53. Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., Kundra, V., Mills, G. B., and Sabbadini, R. A. (2006) Validation of an anti-sphingosine-1- phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9, 225-238
54. Yang, M., Zhong, W. W., Srivastava, N., Slavin, A., Yang, J., Hoey, T., and An, S. (2005) G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc. Natl. Acad. Sci. U. S. A. 102, 6027-6032
55. Yamada, T., Sato, K., Komachi, M., Malchinkhuu, E., Tobo, M., Kimura, T., Kuwabara, A., Yanagita, Y., Ikeya, T., Tanahashi, Y., Ogawa, T., Ohwada, S., Morishita, Y., Ohta, H., Im, D. S., Tamoto, K., Tomura, H., and Okajima, F. (2004) Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J. Biol. Chem. 279, 6595-6605
56. Martin, C. B., Mahon, G. M., Klinger, M. B., Kay, R. J., Symons, M., Der, C. J., and Whitehead, I. P. (2001) The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20, 1953-1963
57. Nierodzik, M. L., and Karpatkin, S. (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10, 355-362
58. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., and Bar-Shavit, R. (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909-914
59. Booden, M. A., Eckert, L. B., Der, C. J., and Trejo, J. (2004) Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion. Mol. Cell. Biol. 24, 1990-1999
60. Seasholtz, T. M., and Brown, J. H. (2004) Rho signaling in vascular diseases. Mol. Interv. 4, 348-357
61. Hill, C. S., Wynne, J., and Treisman, R. (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159-1170
62. Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., and Lacal, J. C. (1997) Activation of the nuclear factor-kB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11, 463-475
63. Menendez, J. A., Vellon, L., Mehmi, I., Teng, P. K., Griggs, D. W., and Lupu, R. (2005) A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 24, 761-779
64. Zhou, D., Herrick, D. J., Rosenbloom, J., and Chaqour, B. (2005) Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. J. Appl. Physiol. 98, 2344-2354
65. Meloche, S., Seuwen, K., Pages, G., and Pouyssegur, J. (1992) Biphasic and synergistic activation of p44 mapk (erk1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6, 845-854
66. Lin, M. T., Zuon, C. Y., Chang, C. C., Chen, S. T., Chen, C. P., Lin, B. R., Wang, M. Y., Jeng, Y. M., Chang, K. J., Lee, P. H., Chen, W. J., and Kuo, M. L. (2005) Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Clin. Cancer Res. 11, 5809-5820
67. Lin, B. R., Chang, C. C., Chen, L. R., Wu, M. H., Wang, M. Y., Kuo, I. H., Chu, C. Y., Chang, K. J., Lee, P. H., Chen, W. J., Kuo, M. L., and Lin, M. T. (2007) Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2. Mol. Cancer Res. 5, 1111-1123
68. Lin, M. T., Chang, C. C., Lin, B. R., Yang, H. Y., Chu, C. Y., Wu, M. H., and Kuo, M. L. (2007) Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. J. Biol. Chem. 282, 34594-34604
69. Chen, C. C., Young, J. L., Monzon, R. I., Chen, N., Todorovic, V., and Lau, L. F. (2007) Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J. 26, 1257-1267
70. Chen, N., Leu, S. J., Todorovic, V., Lam, S. C., and Lau, L. F. (2004) Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J. Biol. Chem. 279, 44166-44176
71. Leu, S. J., Lam, S. C., and Lau, L. F. (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J. Biol. Chem. 277, 46248-46255
72. Babic, A. M., Chen, C. C., and Lau, L. F. (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19, 2958-2966
73. Leu, S. J., Liu, Y., Chen, N., Chen, C. C., Lam, S. C., and Lau, L. F. (2003) Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J. Biol. Chem. 278, 33801-33808
74. Schober, J. M., Lau, L. F., Ugarova, T. P., and Lam, S. C. (2003) Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J. Biol. Chem. 278, 25808-25815
75. Xie, D., Yin, D., Wang, H. J., Liu, G. T., Elashoff, R., Black, K., and Koeffler, H. P. (2004) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin. Cancer Res. 10, 2072-2081
76. Tsai, M. S., Bogart, D. F., Castaneda, J. M., Li, P., Lupu, R. (2002) Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene. 21, 8178-8185
77. Xie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., and Koeffler, H. P. (2001) Breast cancer Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J. Biol. Chem. 276, 14187-14194